Quotient Clinical

Quotient Clinical acquires SeaView Research

Wednesday, February 8, 2017

Quotient Clinical, an early phase drug development services provider, has acquired SeaView Research, expanding its operations into the U.S. The acquisition combines Quotient and SeaView’s complementary customer portfolios, and strengthens the early phase clinical experience of the combined business, enabling the company to deliver a broader set of services.

[Read More]

GHO Capital acquires Quotient Clinical

Wednesday, December 2, 2015

GHO Capital, a European specialist healthcare investor, has acquired Quotient Clinical, a Nottingham, U.K.-based provider of outsourced, early-stage drug development services to the pharmaceutical industry. Employing more than 280 professionals, Quotient Clinical enables pharmaceutical and biotechnology customers to improve R&D productivity and accelerate drug development timelines.

[Read More]

Quotient expands data sciences capabilities

Wednesday, September 9, 2015

Quotient Clinical, a translational pharmaceutics company, has expanded its data sciences services in response to increasing customer demand, doubling the footprint of its facilities in Edinburgh and Nottingham, as well as increasing its specialist headcount and appointing a new vice president.

[Read More]

Bridgepoint Development Capital to acquire Quotient Clinical

Monday, December 16, 2013

Quotient Clinical, a provider of outsourced, early stage drug development services to the pharmaceutical industry, has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum. Employing over 200 people, Quotient Clinical has developed a platform which offers an integrated approach to formulation development, “real-time” drug product manufacturing and clinical testing. Using this platform has been proven to significantly reduce the time and cost of the early stage drug development process.

[Read More]

Quotient Clinical, Capsugel collaborate on lipid-based formulations

Friday, June 29, 2012

Quotient Clinical, a U.K. provider of specialist early stage drug development services, and Capsugel, a Morristown, N.J.-based provider of dosage solutions for the healthcare industry, have formed a collaboration to enable the rapid development and clinical assessment of lipid-based formulations. Together, the companies will use their technology and expertise to address the drug delivery challenges of poorly soluble molecules with limited oral bioavailability.

[Read More]